文献速递胸部心血管CT

肺癌筛查人群的心血管风险:冠状动脉钙化与预防性他汀处方的多中心关联研究

Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription.
PubMed 文献 · J Am Coll Radiol · 2021-02-26

该多中心回顾性研究纳入2016—2018年接受低剂量CT肺癌筛查的5495人,其中31.4%已有动脉粥样硬化性心血管疾病(ASCVD)。在无ASCVD的3771人中,73.6%符合2013年ACC/AHA指南他汀一级预防条件,但60.5%未获他汀处方。CAC与90天内他汀处方相关(调整OR=2.60,95%CI 1.12-6.02),且CAC严重度越高处方可能性越高(调整OR=2.21,95%CI 1.35-3.60)。

要点

  • 肺癌筛查人群中约73.6%符合指南他汀一级预防条件,但60.5%未获处方。
  • CAC存在与90天内他汀处方相关(调整OR=2.60,95%CI 1.12-6.02)。
  • CAC严重度增加与他汀处方可能性升高相关(调整OR=2.21,95%CI 1.35-3.60)。

关键影像表现/征象

  • 5495人中31.4%(1724/5495)有既往ASCVD。
  • 无既往ASCVD的3771人中73.6%(2777/3771)符合他汀一级预防条件。
  • 符合条件者中60.5%(1681/2777)未获他汀处方。
  • CAC存在与90天内他汀处方相关(调整OR=2.60,95%CI 1.12-6.02)。
  • CAC严重度增加与他汀处方可能性升高相关(调整OR=2.21,95%CI 1.35-3.60)。

诊断标准与关键数值

  • 他汀一级预防资格依据2013年ACC/AHA指南:LDL≥190 mg/dL、糖尿病或ASCVD风险评分≥7.5%。
  • CAC严重度从LCS报告中提取,分为轻度、中度、重度。
  • CAC存在与90天内他汀处方相关:调整OR=2.60(95%CI 1.12-6.02)。
  • CAC严重度增加与他汀处方可能性升高相关:调整OR=2.21(95%CI 1.35-3.60)。

临床应用与阅片要点

  • 在肺癌筛查低剂量CT报告中报告CAC存在及严重度(轻度、中度、重度),可能有助于提示ASCVD风险。
  • 放射科医生报告CAC可能为提高ASCVD风险意识和改善预防性他汀处方提供机会。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Coronary artery calcification (CAC) is a marker of atherosclerotic cardiovascular disease (ASCVD), the leading cause of death in individuals receiving lung cancer screening (LCS) with low-dose CT. Our purpose was to determine the proportion of the LCS population eligible for primary ASCVD preventive statin therapy by American College of Cardiology/American Heart Association guidelines, assess statin prescription rates among statin-eligible individuals, and determine associations of CAC on downstream statin prescribing within 90 days of LCS.

METHODS: Individuals receiving LCS between January 1, 2016, and December 31, 2018, across three centers were retrospectively enrolled. Statin eligibility in individuals without pre-existing ASCVD was determined by 2013 American College of Cardiology/American Heart Association guidelines: (1) low-density lipoprotein ≥190 mg/dL, (2) diabetes, or (3) ASCVD risk score ≥7.5%. CAC presence and severity (mild, moderate, heavy) were extracted from LCS reports. Variation in statin prescription rates and associations between CAC and statin prescription were determined using mixed-effects logistic regression.

RESULTS: Of 5,495 individuals receiving LCS, 31.4% (1,724 of 5,495) had pre-existing ASCVD. Of the remaining 3,771 individuals, 73.6% were statin eligible (2,777 of 3,771). However, most lacked statin prescription (60.5%, 1,681 of 2,777). CAC was associated with downstream statin prescribing (adjusted odds ratio = 2.60, 95% confidence interval: 1.12-6.02), with a higher likelihood of statin prescribing with increasing CAC severity (adjusted odds ratio = 2.21, 95% confidence interval: 1.35-3.60).

CONCLUSION: Although most of the LCS population is eligible for guideline-directed statin therapy, statins are underprescribed in this group. Radiologist reporting of CAC at LCS reflects a potential opportunity to raise awareness of ASCVD risk and improve preventive statin prescribing.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Tailor TD, Chiles C, Yeboah J, et al. Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. J Am Coll Radiol. 2021. PMID: 33640340. doi:10.1016/j.jacr.2021.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。